<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-903-SPI-20216</iati-identifier>
  <reporting-org ref="XM-DAC-903" type="40">
   <narrative xml:lang="EN">International Finance Corporation</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Hikma Investment</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Hikma Investment (the company, or Hikma) is a privately held multinational generic pharmaceuticals holding company headquartered in Amman, Jordan.  Manufacturing operations started in 1978 in Jordan, and the company was established in 1991 to consolidate the ownership of all Hikma groups manufacturing subsidiary companies throughout the Middle East, United States, Europe, and North Africa.  Hikma has been an existing client of IFC since 1987. 

The project involves expanding the company&apos;s operations in the Middle East and North Africa region (MENA), Portugal, and Asia. This program is being planned in connection with preparing the company for a future U.S. initial public offering. It will include an IFC corporate governance component to help the company satisfy the recent corporate governance and securities law reform in the U.S. (the Sarbanes-Oxley Act of 2002), which institutes new rules regarding the corporate governance of publicly held corporations listed in the U.S., including American Depositary Receipts (ADRs).</narrative>
  </description>
  <description type="2">
   <narrative xml:lang="EN"></narrative>
  </description>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">HIKMA PHARMACEUTICALS LLC</narrative>
  </participating-org>
  <participating-org activity-id="XM-DAC-903-SPI-20216" ref="XM-DAC-903" role="1" type="40"></participating-org>
  <activity-status code="3"></activity-status>
  <activity-date iso-date="2003-06-27" type="1"></activity-date>
  <activity-date iso-date="2003-07-18" type="2"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">International Finance Corporation</narrative>
   </organisation>
   <telephone>+12024733800</telephone>
   <email>ccspg@ifc.org</email>
   <website>www.ifc.org</website>
   <mailing-address>
    <narrative xml:lang="EN">2121 Pennsylvania Avenue, NW Washington DC 20433</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN">Mr. Bassam Kanaan, Chief Financial Officer
PO Box 182400
Amman 11118
Jordan</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN"></narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="JO" percentage="100">
   <narrative xml:lang="EN">Jordan</narrative>
  </recipient-country>
  <location ref="JO-Jordan">
   <location-reach code="1"></location-reach>
   <location-id code="1453782" vocabulary="G1"></location-id>
   <name>
    <narrative xml:lang="EN">The IFC corporate loan will be extended to Hikma Investment located in Amman, Jordan.  The proceeds will be used to finance expansion of Hikmas operations in the MENA region, Portugal, and Asia.</narrative>
   </name>
   <description>
    <narrative xml:lang="EN">Location description</narrative>
   </description>
   <activity-description>
    <narrative xml:lang="EN">A description that qualifies the activity taking place at the location.</narrative>
   </activity-description>
   <administrative code="1453782" level="1" vocabulary="G1"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>31.0000000000 36.0000000000</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="1"></location-class>
   <feature-designation code="ADMF"></feature-designation>
  </location>
  <sector percentage="100" vocabulary="11" vocabulary-uri="http://www.census.gov/cgi-bin/sssd/naics/naicsrch?chart=2012">
   <narrative xml:lang="EN">FA - Pharmaceuticals and Medicine</narrative>
  </sector>
  <country-budget-items vocabulary="1">
   <budget-item code="7.2.1" percentage="100" vocabulary="1">
    <description>
     <narrative xml:lang="EN">Total: $15.00 million</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="6"></collaboration-type>
  <default-flow-type code="35"></default-flow-type>
  <default-finance-type code="411"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget type="1">
   <period-start iso-date="2003-06-27"></period-start>
   <period-end iso-date="2003-06-30"></period-end>
   <value currency="USD" value-date="2003-06-27">15000000</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2003-06-27"></transaction-date>
   <value currency="USD" value-date="2003-06-27">15000000</value>
   <receiver-org>
    <narrative xml:lang="EN">HIKMA PHARMACEUTICALS LLC</narrative>
   </receiver-org>
   <flow-type code="35"></flow-type>
   <finance-type code="411"></finance-type>
  </transaction>
  <document-link format="TEXT/HTML" url="https://disclosures.ifc.org/project-detail/SPI/20216/hikma-investment">
   <title>
    <narrative xml:lang="EN">Summary of Project Information</narrative>
   </title>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
 </iati-activity>
</iati-activities>
